Cargando…
A positive feedback between IDO1 metabolite and COL12A1 via MAPK pathway to promote gastric cancer metastasis
BACKGROUND: IDO1 (Indoleamine 2,3-dioxygenase 1) inhibits host anti-tumor immune response by exhausting tryptophan in tumor microenvironment, but the pathogenic mechanisms of IDO1 in gastric cancer (GC) cells need to be further explored. METHODS: The aim of this study was to use CCLE (Cancer Cell Li...
Autores principales: | Xiang, Zhen, Li, Jun, Song, Shuzheng, Wang, Jiexuan, Cai, Wei, Hu, Wenjun, Ji, Jun, Zhu, Zhenggang, Zang, Lu, Yan, Ranlin, Yu, Yingyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637527/ https://www.ncbi.nlm.nih.gov/pubmed/31315643 http://dx.doi.org/10.1186/s13046-019-1318-5 |
Ejemplares similares
-
Dexamethasone suppresses immune evasion by inducing GR/STAT3 mediated downregulation of PD-L1 and IDO1 pathways
por: Xiang, Zhen, et al.
Publicado: (2021) -
Cross-Database Analysis Reveals Sensitive Biomarkers for Combined Therapy for ERBB2+ Gastric Cancer
por: Xiang, Zhen, et al.
Publicado: (2018) -
A Novel Citrullinated Modification of Histone 3 and Its Regulatory Mechanisms Related to IPO-38 Antibody-Labeled Protein
por: Song, Shuzheng, et al.
Publicado: (2019) -
Genetic Profiles Affect the Biological Effects of Serine on Gastric Cancer Cells
por: Li, Jun, et al.
Publicado: (2020) -
Tracking cancer lesions on surgical samples of gastric cancer by artificial intelligent algorithms
por: Yang, Ruixin, et al.
Publicado: (2021)